ArticleExperimental & molecular medicine2017

Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo.

Ke Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.